仙乐健康 (300791)
Sirio Pharma Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 30763.47
- Circulating A-Shares(W): 25652.49
- Earnings Per Share(RMB): 0.8523
- Net Assets Per Share(RMB): 7.9801
- Operating Revenue(W RMB): 329117.39
- Total Profit(W RMB): 25495.58
- Net Profit Attributable to Parent(W RMB): 26026.75
- Net Profit Growth Rate(%): 8.53
- Weighted Return on Equity(%): 10.0700
- Operating Cash Flow Per Share(RMB): 1.3380
- Undistributed Profit Per Share(RMB): 5.2805
- Capital Reserve Per Share(RMB): 1.4707
2. Main Business
The main business covers:
- Nutrition and health food contract research and production
3. Company Basic Information
- Company Name: Sirio Pharma Co., Ltd.
- Listing Date: 2019-09-25
- Industry: Food Manufacturing
- Address: No. 83 Taishan Road, Shantou City, Guangdong Province
- Website: www.siriopharma.com
- Company Profile: The issuer's predecessor was Xianle Co., Ltd., established on August 16, 1993. In April 2015, Xianle Co., Ltd. was wholly transformed into a joint-stock company. On April 8, 2015, all shareholders of Xianle Co., Ltd. signed the "Sponsor Agreement". The sponsors agreed to convert the audited net assets of RMB 174,007,807.96 as of February 28, 2015, as per the audit report issued by Zhengzhong Zhujiang (Guanghui Audit No. [2015]G14010260076), into 60,000,000 shares at a ratio of 2.90:1. The remaining net assets of RMB 114,007,807.96 were recorded as the company's capital reserve. The sponsors converted their respective share of the registered capital in Xianle Co., Ltd. into their corresponding share proportion in the joint-stock company. On April 23, 2015, Zhengzhong Zhujiang issued the "Capital Verification Report" (Guanghui Verification No. [2015]G14010260088) to verify the above capital contribution. On April 24, 2015, the company registered with the Shantou Administration for Industry and Commerce and obtained the "Business License of Enterprise Legal Person" (Registration No. 440500400001710), with a registered capital of 60 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guangdong Guanghui Investment Co., Ltd. | General Legal Person | 13141.44 | 51.23 |
| 2 | Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. - Xuanyuan Kexin No. 273 Private Securities Investment Fund | Private Securities Investment Fund | 610.08 | 2.38 |
| 3 | Zhuhai Abama Private Fund Management Co., Ltd. - Abama Yuexiang Hongli No. 96 Private Securities Investment Fund | Private Securities Investment Fund | 569.46 | 2.22 |
| 4 | Orient Securities (Hong Kong) JD Big Data Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 388.35 | 1.51 |
| 5 | Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Changyang No. 11 Private Securities Investment Fund | Private Securities Investment Fund | 330.00 | 1.29 |
| 6 | Shanghai Yuanhong Investment Management Co., Ltd. - Yuanhong Shangshan No. 1 Private Securities Investment Fund | Private Securities Investment Fund | 275.29 | 1.07 |
| 7 | Orient Securities (Hong Kong) New Power Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 219.99 | 0.86 |
| 8 | Everbright Pramerica Credit Tianyi Bond Securities Investment Fund Class A | Fund | 203.29 | 0.79 |
| 9 | Orient Securities (Hong Kong) Core Value Hybrid Securities Investment Fund Class A | Fund | 195.61 | 0.76 |
| 10 | Orient Securities (Hong Kong) Zhixiang Three-Year Holding Period Hybrid Securities Investment Fund Class A | Fund | 52.04 | 0.20 |
5. Concept Sectors
- Convertible Bonds
- Vitamins
- Pet Economy
- DeepSeek
- High-Performance Stocks
- Heavily Held by Private Funds
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information